Jason Cole

General Counsel, EPIRUS Biopharmaceuticals, Inc.

Companies

bluebird bioChief Business Officer Nov 17, 2021 to Aug 23, 2022¹
bluebird bioGeneral counsel Mar 12, 2014 to Feb 5, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

bluebird bio BLUE189,546 shares³Aug 19, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 19, 2022Sold 14,194 shares at $5.53 of bluebird bio³
Aug 4, 2022Sold 7,448 shares at $4.39 of bluebird bio⁴
Feb 1, 2022Granted 25,000 shares of bluebird bio⁵
Jan 11, 2022Sold 3,387 shares at $9.64 of bluebird bio⁶
Jan 10, 2022Sold 1,584 shares at $9.40 of bluebird bio⁶
Nov 11, 2021Other 64,779 shares of bluebird bio⁷
Nov 11, 2021Other 64,781 shares of bluebird bio⁷
Nov 11, 2021Other 27,606 shares of bluebird bio⁷
Nov 11, 2021Other 6,645 shares of bluebird bio⁷
Nov 11, 2021Other 3,077 shares of bluebird bio⁷
Nov 11, 2021Other 1,539 shares of bluebird bio⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARbluebird bio, Chief Business Officer
2
SEC EDGARbluebird bio, General counsel
3
SEC EDGARbluebird bio shares after the filing of Aug 19, 2022
4
SEC EDGARForm 4 filed Aug 8, 2022
5
SEC EDGARForm 4 filed Feb 3, 2022
6
SEC EDGARForm 4 filed Jan 12, 2022
7
SEC EDGARForm 4 filed Nov 17, 2021